Please assess the completion status of the following clinical trial:

Trial Title: Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females between ages of 18 and 50~* Enrolled in RNP methadone program and stable on methadone for at least 3 weeks~* Current cocaine abuse or dependence according to DSM-IV criteria~* No current medical problems and normal ECG~* If female, not currently pregnant or breast feeding and using reliable birth control~* Fluent in English and have at least a 6th grade reading level~* Can commit to 12 weeks of treatment and are willing to be randomized~Exclusion Criteria:~* Current major psychiatric illness including mood, psychotic or anxiety disorder~* History of major medical illnesses including asthma, chronic obstructive lung disease, gastrointestinal ulcer, hepatic or renal impairment, cardiac rhythm disturbances~* Use of medications including beta blockers and NASAIDs~* Known allergy to Galantamine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Standard Treatment As Usual (TAU) (Type: NO_INTERVENTION): Standard Treatment plus placebo for cocaine abusing or dependent methadone-maintained individuals. This consists of daily methadone visits plus one individual and one group session per week, and patients may participate in additional treatments such as HIV education and treatment. The counseling program's theoretical orientation is described as client-centered.
- TAU Plus Galantamine (Type: EXPERIMENTAL): Standard treatment plus Galantamine. In this study, we will use 8 mg galantamine extended release (ER). Galantamine ER is used once daily. The recommended initial dose is 8 mg/day and the maintenance dose is 16-24 mg/day.
- TAU plus Computer Assisted Cognitive Behavioral Therapy (CBT) (Type: EXPERIMENTAL): TAU plus computer assisted CBT plus placebo. All participants assigned to this condition will also be offered up to 60 minutes per week to work with the CBT for CBT program, onsite at the clinic, in a private space and using a computer provided by the research project. Patients will have the choice of how they choose to use the computer, that is, in two 30-minute sessions or one one-hour session.
- TAU plus CBT plus galantamine (Type: EXPERIMENTAL): Standard treatment, plus computer assisted cognitive behavioral therapy, plus galantamine.

Based on this trial design, predict the completion outcome and termination type (if applicable).